Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH" (original) (raw)

Abstract

An 18-yr-old woman with clinical and laboratory features of hyperthyroidism had persistently elevated serum levels of immunoreative thyrotropin (TSH). During 11 yr of follow-up there had been no evidence of a pituitary tumor. After thyrotropin-releasing hormone (TRH), there was a marked increase in TSH and secondarily in triiodothyronine (T3), the latter observation confirming the biologic activity of the TSH. Exogenous T3 raised serum T3 and several measurements of peripheral thyroid hormone effect, while decreasing serum TSH, thyroxine (T4), and thyroidal radioiodine uptake. After T3, the TRH-stimulated TSH response was decreased but was still inappropriate for the elevated serum T3 levels. Dexamethasone reduced serum TSH but did not inhibit TRH stimulation of TSH. Propylthiouracil reduced serum T4 and T3 and raised TSH. This patient represents a new syndrome of TSH-induced hyperthyroidism, differing from previous reports in the absence of an obvious pituitary tumor and in the responsiveness of the TSH to TRH stimulation and thyroid hormone suppression. This syndrome appears to be caused by a selective, partial resistance of the pituitary to the action of thyroid hormone. This case is also compared with previous reports in the literature of patients with elevated serum levels of immunoreactive TSH in the presence of elevated total and free thyroid hormones. A classification of these cases, termed "inappropriate secretion of TSH," is proposed.

633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bode H. H., Danon M., Weintraub B. D., Maloof F., Crawford J. D. Partial target organ resistance to thyroid hormone. J Clin Invest. 1973 Apr;52(4):776–782. doi: 10.1172/JCI107240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burgess J. A., Smith B. R., Merimee T. J. Growth hormone in thyrotoxicosis: effect of insulin-induced hypoglycemia. J Clin Endocrinol Metab. 1966 Nov;26(11):1257–1260. doi: 10.1210/jcem-26-11-1257. [DOI] [PubMed] [Google Scholar]
  3. Eddy R. L., Gilliland P. F., Ibarra J. D., Jr, McMurry J. F., Jr, Thompson J. Q. Human growth hormone release. Comparison of provocative test procedures. Am J Med. 1974 Feb;56(2):179–185. doi: 10.1016/0002-9343(74)90595-6. [DOI] [PubMed] [Google Scholar]
  4. Emerson C. H., Utiger R. D. Hyperthyroidism and excessive thyrotropin secretion. N Engl J Med. 1972 Aug 17;287(7):328–333. doi: 10.1056/NEJM197208172870704. [DOI] [PubMed] [Google Scholar]
  5. Faglia G., Ferrari C., Neri V., Beck-Peccoz P., Ambrosi B., Valentini F. High plasma thyrotrophin levels in two patients with pituitary tumour. Acta Endocrinol (Copenh) 1972 Apr;69(4):649–658. doi: 10.1530/acta.0.0690649. [DOI] [PubMed] [Google Scholar]
  6. Furth J., Moy P., Hershman J. M., Ueda G. Thyrotropic tumor syndrome. A multiglandular disease induced by sustained deficiency of thyroid hormones. Arch Pathol. 1973 Oct;96(4):217–226. [PubMed] [Google Scholar]
  7. Galton V. A., Inggar S. H., Jimenez-Fonseca J., Hershman J. M. Alterations in thyroid hormone economy in patients with hydatidiform mole. J Clin Invest. 1971 Jun;50(6):1345–1354. doi: 10.1172/JCI106614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goolden A. W., Bateman D., Torr S. Red cell sodium in hyperthyroidism. Br Med J. 1971 Jun 5;2(5761):552–554. doi: 10.1136/bmj.2.5761.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Greenwood F. C., Landon J., Stamp T. C. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest. 1966 Apr;45(4):429–436. doi: 10.1172/JCI105357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haigler E. D., Jr, Pittman J. A., Jr, Hershman J. M., Baugh C. M. Direct evaluation of pituitary thyrotopin reserve utilizing synthetic thyrotopin releasing hormone. J Clin Endocrinol Metab. 1971 Oct;33(4):573–581. doi: 10.1210/jcem-33-4-573. [DOI] [PubMed] [Google Scholar]
  11. Hamilton C. R., Jr, Adams L. C., Maloof F. Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma. N Engl J Med. 1970 Nov 12;283(20):1077–1080. doi: 10.1056/NEJM197011122832003. [DOI] [PubMed] [Google Scholar]
  12. Hamilton C. R., Jr, Maloof F. Acromegaly and toxic goiter. Cure of the hyperthyroidism and acromegaly by proton-beam partial hypophysectomy. J Clin Endocrinol Metab. 1972 Nov;35(5):659–664. doi: 10.1210/jcem-35-5-659. [DOI] [PubMed] [Google Scholar]
  13. Hershman J. M., Higgins H. P. Hydatidiform mole--a cause of clinical hyperthyroidism. Report of two cases with evidence that the molar tissue secreted a thyroid stimulator. N Engl J Med. 1971 Mar 18;284(11):573–577. doi: 10.1056/NEJM197103182841103. [DOI] [PubMed] [Google Scholar]
  14. Hershman J. M., Pittman J. A., Jr Utility of the radioimmunoassay of serum thyrotrophin in man. Ann Intern Med. 1971 Apr;74(4):481–490. doi: 10.7326/0003-4819-74-4-481. [DOI] [PubMed] [Google Scholar]
  15. Lamberg B. A. Congenital euthyroid goitre and partial peripheral resistance to thyroid hormones. Lancet. 1973 Apr 21;1(7808):854–857. doi: 10.1016/s0140-6736(73)91421-9. [DOI] [PubMed] [Google Scholar]
  16. Mitsuma T., Nihei N., Gershengorn M. C., Hollander C. S. Serum triiodothyronine: measurements in human serum by radioimmunoassay with corroboration by gas-liquid chromatography. J Clin Invest. 1971 Dec;50(12):2679–2688. doi: 10.1172/JCI106769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mornex R., Tommasi M., Cure M., Farcot J., Orgiazzi J., Rousset B. Hyperthyroïdie associee á un hypopituitarisme au cours de l'evolution d'une tumeur hypophysaire secretant T.S. Ann Endocrinol (Paris) 1972 Jul-Aug;33(4):390–396. [PubMed] [Google Scholar]
  18. Nisula B. C., Morgan F. J., Canfield R. E. Evidence that chorionic gonadotropin has intrinsic thyrotropic activity. Biochem Biophys Res Commun. 1974 Jul 10;59(1):86–91. doi: 10.1016/s0006-291x(74)80178-6. [DOI] [PubMed] [Google Scholar]
  19. O'Donnell J., Hadden D. R., Weaver J. A., Montgomery D. A. Thyrotoxicosis recurring after surgical removal of a thyrotrophin-secreting pituitary tumour. Proc R Soc Med. 1973 May;66(5):441–442. [PMC free article] [PubMed] [Google Scholar]
  20. Odell W. D., Wilber J. F., Utiger R. D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res. 1967;23:47–85. doi: 10.1016/b978-1-4831-9826-2.50005-2. [DOI] [PubMed] [Google Scholar]
  21. Ormston B. J., Cryer R. J., Garry R., Besser G. M., Hall R. Thyrotrophin-releasing hormone as a thyroid-function test. Lancet. 1971 Jul 3;2(7714):10–14. doi: 10.1016/s0140-6736(71)90005-5. [DOI] [PubMed] [Google Scholar]
  22. ROBERTSON J. D., REID D. D. Standards for the basal metabolism of normal people in Britain. Lancet. 1952 May 10;1(6715):940–943. doi: 10.1016/s0140-6736(52)90543-6. [DOI] [PubMed] [Google Scholar]
  23. Rabello M. M., Snyder P. J., Utiger R. D. Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH). J Clin Endocrinol Metab. 1974 Sep;39(3):571–578. doi: 10.1210/jcem-39-3-571. [DOI] [PubMed] [Google Scholar]
  24. Rasmussen S. N., Hjorth L. Determination of thyroid volume by ultrasonic scanning. J Clin Ultrasound. 1974 Jun;2(2):143–147. doi: 10.1002/jcu.1870020211. [DOI] [PubMed] [Google Scholar]
  25. Refetoff S., DeGroot L. J., Benard B., DeWind L. T. Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone. Metabolism. 1972 Aug;21(8):723–756. doi: 10.1016/0026-0495(72)90121-7. [DOI] [PubMed] [Google Scholar]
  26. Refetoff S., DeWind L. T., DeGroot L. J. Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab. 1967 Feb;27(2):279–294. doi: 10.1210/jcem-27-2-279. [DOI] [PubMed] [Google Scholar]
  27. Reichlin S., Martin J. B., Mitnick M., Boshans R. L., Grimm Y., Bollinger J., Gordon J., Malacara J. The hypothalamus in pituitary-thyroid regulation. Recent Prog Horm Res. 1972;28:229–286. [PubMed] [Google Scholar]
  28. Ridgway E. C., Weintraub B. D., Cevallos J. L., Rack M. C., Maloof F. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest. 1973 Nov;52(11):2783–2792. doi: 10.1172/JCI107474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rodbard D., Fujita T., Rodbard S. Estimation of thyroid function by timing the arterial sounds. JAMA. 1967 Sep 11;201(11):884–887. [PubMed] [Google Scholar]
  30. Rogol A. D., Rosen S. W. Alteration of human and bovine prolactins by a chloramine T radioiodination: comparison with lactoperoxidase-iodinated prolactins. J Clin Endocrinol Metab. 1974 Aug;39(2):379–382. doi: 10.1210/jcem-39-2-379. [DOI] [PubMed] [Google Scholar]
  31. Saberi M., Utiger R. D. Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J Clin Endocrinol Metab. 1974 Nov;39(5):923–927. doi: 10.1210/jcem-39-5-923. [DOI] [PubMed] [Google Scholar]
  32. Samuels H. H., Tsai J. S. Thyroid hormone action in cell culture: domonstration of nuclear receptors in intact cells and isolated nuclei. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3488–3492. doi: 10.1073/pnas.70.12.3488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Snyder P. J., Jacobs L. S., Utiger R. D., Daughaday W. H. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest. 1973 Sep;52(9):2324–2329. doi: 10.1172/JCI107421. [DOI] [PMC free article] [PubMed] [Google Scholar]